MyGeneRank: Understanding Genetic Risk for Heart Disease
This study, called MyGeneRank, is exploring how genetic information can help us understand the risk of heart diseases. Researchers are providing participants with genetic risk information, specifically risk scores, through a special app called ResearchKit. The main goal is to see if receiving this genetic risk information influences whether people start taking statin therapy (medication to lower cholesterol) within six months. You can join if you are 18 or older, are a 23andMe customer willing to share your data, and use an Apple mobile device. The study aims to enroll 100,000 people.
- Study design
- This is an interventional study, meaning participants receive a specific intervention (genetic risk information). It plans to include 100,000 participants.
- What's involved
- You would need to be a 23andMe customer willing to share your data and use an Apple mobile device to receive genetic risk information through the ResearchKit app.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures the initiation of statin therapy at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
At a glance
Conditions
NCT03277365
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Scripps Translational Science Institute
La Jolla, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Initiation of Statin Therapy6 months
Participant begins taking Statin as indicated by survey.